Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma-Reference-Cited by-同舟云学术

Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma

Published:2023-10 Issue: Volume:299 Page:122838
ISSN:1386-1425
Container-title:Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
language:en
Short-container-title:Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy

Author:

Salem Hesham^ORCID,Abdelaziz Amany,Galal Mariam,Hussien Maha,Emad Nadeen,Batekh Asmaa E.,Karem Mohamed,Moukhtar Deena A.

Publisher

Elsevier BV

Subject

Spectroscopy,Instrumentation,Atomic and Molecular Physics, and Optics,Analytical Chemistry

Reference47 articles.

1. Verupharma. ENTADFI™ (finasteride and tadalafil) capsule, a new treatment of an enlarged prostate called benign prostatic hyperplasia (BPH).Miami: Veru; 2021.

2. A. Casabé, C.G. Roehrborn, L.F. Da Pozzo, S. Zepeda, R.J. Henderson, S. Sorsaburu, C. Henneges, D.G. Wong, L. Viktrup, Efficacy and safety of the co-administration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia, J. Urol.191 (2014) 727–33. https://doi.org/10.1016/j.juro.2013.09.059.

3. D.D. Nguyen, Q.D. Trinh, N. Bhojani, Combination of tadalafil and finasteride for the treatment of urinary tract symptoms related to benign prostatic hyperplasia: commercialization of the prescribing cascade, Eur. Urol. 81 (2022) 323–4. https://doi.org/10.1016/j.eururo.2022.01.009.

4. O.O. Elkelany, R.C. Owen, E.D. Kim, Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus, Ther. Clin. Risk Manage. 2015;11:507–13. https://doi.org/10.2147/TCRM.S80353.

5. Olesovsky C, Kapoor A. Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia. Ther Adv Urol. 2016;8:257–71. https://doi.org/10.1177/1756287216650132.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrofluorimetric determination of tapinarof via Zn (II) complexation and assessment of its topical dosage application;BMC Chemistry;2024-09-10

2. Eco-friendly screening method for sulfonamides using a 3D handheld smartphone-based fluorescence detection device and graphene nanoplatelet-packed pipette tip microextraction;Journal of Environmental Chemical Engineering;2024-04

3. Assessing the Greenness and Environmental Friendliness of Analytical Methods: Modern Approaches and Recent Computational Programs;Critical Reviews in Analytical Chemistry;2024-01-19

4. Insights on ecological spectroscopic techniques recently adopted for pharmaceutical analysis: A comprehensive review from the perspective of greenness assessment metrics systems application;TrAC Trends in Analytical Chemistry;2024-01

5. Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-01